Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma

Saved in:
Bibliographic Details
Main Author: Emergency Medicine International
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Emergency Medicine International
Online Access:http://dx.doi.org/10.1155/2024/9795276
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558435939385344
author Emergency Medicine International
author_facet Emergency Medicine International
author_sort Emergency Medicine International
collection DOAJ
format Article
id doaj-art-29594b15cc6746d487e4cca148f0e4e5
institution Kabale University
issn 2090-2859
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Emergency Medicine International
spelling doaj-art-29594b15cc6746d487e4cca148f0e4e52025-02-03T01:32:22ZengWileyEmergency Medicine International2090-28592024-01-01202410.1155/2024/9795276Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal CarcinomaEmergency Medicine Internationalhttp://dx.doi.org/10.1155/2024/9795276
spellingShingle Emergency Medicine International
Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
Emergency Medicine International
title Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
title_full Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
title_fullStr Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
title_full_unstemmed Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
title_short Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
title_sort retracted clinical effect of apatinib mesylate tablets combined with paclitaxel concurrent radiotherapy and chemotherapy in the first line treatment of locally advanced nasopharyngeal carcinoma
url http://dx.doi.org/10.1155/2024/9795276
work_keys_str_mv AT emergencymedicineinternational retractedclinicaleffectofapatinibmesylatetabletscombinedwithpaclitaxelconcurrentradiotherapyandchemotherapyinthefirstlinetreatmentoflocallyadvancednasopharyngealcarcinoma